Zdrowie i gospodarka · 10/02/2023

FDA Withdraws Guidance on Propofol Repackaging Policy

The FDA is withdrawing its temporary policy on repackaging or combining propofol drug products during the COVID-19 public health emergency, as the conditions that created the need for the policy have evolved.